Obermatt
See Similar Stocks →

PMV Pharmaceuticals

NSQ:PMVP · US69353Y1038
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings7
Price/Book42
Dividend Yield—
Revenue Growth—
Profit Growth56
Capital Growth6
TSR 52w28
Leverage93
Liquidity23
Refinancing11
Combined—
Analyst Opinions100
Pro Holdings53
Opinion Changes6
Market Pulse17

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2013
Employees58
Websitepmvpharma.com
ISINUS69353Y1038
Last UpdateApr 2, 2026
Index & Theme
GeneticsOncologyBiopharmaHealth CareMedical Device

Description

PMV Pharmaceuticals, Inc. operates as a precision oncology company. The company engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a well-defined tumor suppressor protein known as the 'guardian…

Similar Stocks

The companies this stock is ranked against.

Compare PMV Pharmaceuticals with its peers
Elicio Therapeutics
NAQ:ELTX
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Palvella Therapeutics
NAQ:PVLA
100
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Lexeo Therapeutics
NMQ:LXEO
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
IDEAYA Biosciences
NSQ:IDYA
18
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Syndax Pharmaceuticals
NSQ:SNDX
59
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Legend Biotech
NSQ:LEGN
30
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →